Access cutting-edge advanced solid tumors treatment through this clinical trial at a research site in Louisville. Study-provided care at no cost to qualified participants.
Access advanced solid tumors specialists in Louisville at no cost
This study follows strict safety protocols and ethical guidelines
All study-related advanced solid tumors treatment provided free
This study is a phase 1B/2 open-label, study to determine safety and preliminary efficacy of Q702 in combination with pembrolizumab in study subjects with advanced esophageal, gastric/GEJ, hepatocellular, and cervical cancers.
Sponsor: Qurient Co., Ltd.
Check if you qualify for this advanced solid tumors clinical trial in Louisville, KY
If you're searching for advanced solid tumors treatment options in Louisville, KY, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Louisville research site is actively enrolling participants for this clinical trial. You'll receive care from experienced advanced solid tumors specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.